Developing medicines to help patients
At INVENT pharmaceuticals, we transform novel molecules into highly effective and safer medicines by innovative molecular drug design, discovery and development chemistry, biology, pharmacology, technology, all data, intelligence and creativity to help improve patients lives.
Cardiovascular, Pulmonary, Renal and Metabolic diseases affect over billion people wordwide. Cardiovascular, cardiopulmonary, cardiorenal and cardiometabolic diseases are the primary drivers for higher mortality in the US compared to other western countrie
INVENT Pharmaceuticals is developing new therapeutics for treatment of cardiovascular, pulmonary, renal, metabolic and other diseases.
We design, discover and develop new medicines by applying our powerful precision drug design and discovery platform. INVENT Pharmaceuticals' approach integrates its molecular design with target selection, precision drug design, medicinal chemistry and drug discovery, site-specific precision deuterium substitution strategy, in vitro and in vivo pharmacology, and deep domain knowledge, expertise and capabilities.
Cardiovascular Pulmonary Renal and Metabolic Diseases
• Pulmonary Arterial Hypertension (PAH)
• Renal Disease
• Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
• Uncontrolled/Resistance Hypertension (u/rHTN)
Central Nervous System (CNS) Diseases and Disorders
• Alzheimer's Disease (AD)
• Cognitive Impairment Associated with Schizophrenia (CIAS)
• Neuropsychiatric disorders
Fibrotic Diseases:
• Liver Fibrosis
• Small-Intestine Neuroendocrine Tumors (SI-NET)
